12:00 AM
Dec 06, 2010
 |  BC Week In Review  |  Company News  |  Management Tracks

Dyax management update

Dyax Corp. (NASDAQ:DYAX), Cambridge, Mass.
Business: Inflammation, Ophthalmic, Antibodies

Read the full 26 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >